You are here: Home » News-CM » Companies » Results
Business Standard

Fredun Pharmaceuticals reports standalone net profit of Rs 0.23 crore in the June 2019 quarter

Capital Market 

Sales rise 73.66% to Rs 28.22 crore

Net profit of Fredun Pharmaceuticals reported to Rs 0.23 crore in the quarter ended June 2019 as against net loss of Rs 0.63 crore during the previous quarter ended June 2018. Sales rose 73.66% to Rs 28.22 crore in the quarter ended June 2019 as against Rs 16.25 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales28.2216.25 74 OPM %6.951.17 -PBDT0.69-0.15 LP PBT0.23-0.63 LP NP0.23-0.63 LP

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 14 2019. 15:21 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU